Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|September 4, 2012
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trialEdith Roset Bahmanyar, Jorma Paavonen, Paulo Naud, et al.
BMC Infectious Diseases|May 1, 2015
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trialXavier Castellsagué, Jorma Paavonen, Unnop Jaisamrarn, et al.
Journal of Medical Virology|April 14, 2021
Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A report of two casesMaria C Mendes Correa, Fabio E Leal, Lucy S Villas Boas, et al.
Chemistry & Biology|June 23, 2015
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrGGiorgia Mori, Laurent R Chiarelli, Marta Esposito, et al.
The Journal of Infectious Diseases|October 5, 2013
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observationAnne Szarewski, S Rachel Skinner, Suzanne M Garland, et al.
The Journal of Infectious Diseases|March 11, 2014
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIAXavier Castellsagué, Paulo Naud, Song-Nan Chow, et al.
Plos One|November 22, 2013
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA studyUnnop Jaisamrarn, Xavier Castellsagué, Suzanne M Garland, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
The Natural Products Discovery Center: Release of the First 8490 Sequenced Strains for Exploring Actinobacteria Biosynthetic DiversityEdward Kalkreuter, Satria A Kautsar, Dong Yang, et al.
The Lancet. Oncology|November 15, 2011
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialMatti Lehtinen, Jorma Paavonen, Cosette M Wheeler, et al.
Journal of Medicinal Chemistry|October 3, 2017
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular ActivityGuilherme Felipe Dos Santos Fernandes, Paula Carolina de Souza, Elsa Moreno-Viguri, et al.
Pageof 20